蚊媒疾病市场：依疾病类型、治疗类型、最终使用者、地区

全球蚊媒疾病市场规模预计将从 2023 年的 31.1 亿美元增至 2030 年的 51 亿美元，预测期内复合年增长率为 7.3%。

图 1. 2023 年按地区分類的蚊媒疾病全球市场占有率(%)

蚊媒疾病是世界多个地区的重大公共卫生问题。这些疾病透过受感染的蚊子叮咬传播，威胁人类生命并造成重大疾病负担。对抗蚊媒疾病的创新解决方案是开发驱蚊石板。这种石板可以有效阻挡蚊子，降低疟疾、登革热和兹卡病毒等疾病的风险。

市场动态：

由于蚊媒疾病的盛行率不断上升以及人们对其对公共卫生影响的认识不断增强，预计全球蚊媒疾病市场在不久的将来将出现显着增长。政府和医疗机构大力投资研发，以开发有效的诊断和治疗方法。杀虫剂和捕蚊器等灭蚊方法的技术进步进一步促进了市场的成长。然而，也存在一些需要解决的挑战。市场成长的主要抑制因素之一是缺乏对医疗保健设施的认识和使用机会，特别是在新兴国家。有限的卫生基础设施、资金不足和卫生条件不佳导致了蚊媒疾病的传播。此外，蚊子抗药性的开拓和疫苗开发的复杂性为市场带来了重大挑战。

儘管有这些挑战，全球蚊媒疾病市场仍存在巨大机会。新诊断工具、治疗方法和疫苗的开发提供了潜在的成长前景。此外，製药公司、研究机构和政府之间的合作和伙伴关係可能会加速蚊子控制和预防创新解决方案的开发。

本研究的主要特点

• 本报告对全球蚊媒疾病市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030年）的市场规模和年复合成长率（CAGR%）。
• 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
• 根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球蚊媒疾病市场的主要企业进行了分析。
• 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
• 全球蚊媒疾病市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析家。
• 透过用于分析全球蚊媒疾病市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与假设

• 研究目标
• 假设
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章全球蚊媒疾病市场 -冠状病毒(COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章全球蚊媒疾病市场，依疾病类型，2018-2030

• 介绍
• 疟疾
• 登革热
• 发烧
• 西尼罗病毒
• 基孔肯雅热
• 兹卡病毒
• 其他的

第六章 全球蚊媒疾病市场，依治疗类型，2018-2030 年

• 介绍
• 剂量
• 疫苗接种
• 向量控制方式
• 免疫疗法
• 支持性护理
• 其他的

第 7 章 全球蚊媒疾病市场，依最终使用者划分，2018-2030 年

• 介绍
• 医院
• 诊所
• 诊断中心
• 研究机构
• 政府机关
• NGO
• 其他的

第八章全球蚊媒疾病市场（按地区），2018-2030

• 介绍
• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 欧洲其他地区
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 东南亚国协
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 南非
• 北非
• 中部非洲

第9章竞争形势

• GlaxoSmithKline plc
• Sanofi SA
• Pfizer Inc.
• Merck & Co., Inc.
• Novartis AG
• Johnson & Johnson
• Eisai Co., Ltd
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Valeant Pharmaceuticals International, Inc.
• Mitsubishi Tanabe Pharma Corporation
• Abbott
• Hoffmann-La Roche Ltd
• Sun Pharmaceutical Industries Ltd
• Lupin Pharmaceuticals, Inc.
• BioCryst Pharmaceuticals, Inc.
• Mallinckrodt Pharmaceuticals
• Serum Institute of India Pvt. Ltd.
• CSL Limited
• Teva Pharmaceutical Industries Ltd

第10章

• 调查方法
• 关于出版商

Global mosquito borne disease market size is expected to reach US$ 5.10 Bn by 2030, from US$ 3.11 Bn in 2023, exhibiting a CAGR of 7.3% during the forecast period.

Figure 1. Global Mosquito Borne Disease Market Share (%), By Region, 2023

Mosquito borne disease have been a significant public health concern in several parts of the world. These diseases, transmitted through the bite of infected mosquitoes, pose a threat to human lives, and are responsible for a considerable disease burden. One innovative solution to combat mosquito borne diseases is the development of a stone slab that repels mosquitoes, and thus, offering protection to individuals. This stone slab acts as an effective barrier against mosquitoes, reducing the risk of diseases such as malaria, dengue fever, and Zika virus.

Market Dynamics:

Global mosquito borne disease market is expected to witness significant growth in the near future due to increasing incidence of mosquito-borne diseases, coupled with growing awareness about their impact on public health. Governments and healthcare organizations are investing heavily in research and development to develop effective diagnostics and treatment options. Technological advancements in mosquito control methods such as insecticides and mosquito traps are further contributing to market growth. However, there are also several challenges that need to be addressed. One of the major restraints for the market growth is the lack of awareness and access to healthcare facilities, particularly in developing countries. Limited healthcare infrastructure, inadequate funding, and poor sanitation contribute to the spread of mosquito-borne diseases. Furthermore, the development of drug resistance in mosquitoes and the complexity of vaccine development pose significant challenges to the market.

Despite these challenges, there are significant opportunities in the global mosquito borne disease market. The development of new diagnostic tools, therapeutic drugs, and vaccines offers potential growth prospects. Moreover, collaborations and partnerships between pharmaceutical companies, research institutions, and governments are likely to accelerate the development of innovative solutions for mosquito control and prevention.

Key features of the study:

• This report provides in-depth analysis of the global mosquito borne disease market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global mosquito borne disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, Eisai Co., Ltd, Takeda Pharmaceutical Company Limited, AstraZeneca, Valeant Pharmaceuticals International, Inc., Mitsubishi Tanabe Pharma Corporation, Abbott , F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals, Inc., BioCryst Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, and Teva Pharmaceutical Industries Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global mosquito borne disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mosquito borne disease market

Global Mosquito Borne Disease Market Detailed Segmentation:

• By Disease Type
  • Malaria
  • Dengue
  • Yellow Fever
  • West Nile Virus
  • Chikungunya
  • Zika Virus
  • Others
• By Treatment Type
  • Medication
  • Vaccination
  • Vector Control Methods
  • Immunotherapy
  • Supportive Care
  • Others
• By End User
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Research Institutes
  • Government Organizations
  • NGOs
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Key Players:
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Johnson & Johnson
  • Eisai Co., Ltd
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca
  • Valeant Pharmaceuticals International, Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Abbott
  • Hoffmann-La Roche Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Pharmaceuticals, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • Serum Institute of India Pvt. Ltd.
  • CSL Limited
  • Teva Pharmaceutical Industries Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Mosquito Borne Disease, By Disease Type
  • Market Mosquito Borne Disease, By Treatment Type
  • Market Mosquito Borne Disease, By End User
  • Market Mosquito Borne Disease, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Mosquito Borne Disease Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Mosquito Borne Disease Market, By Disease Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Malaria
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Dengue
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Yellow Fever
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• West Nile Virus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Chikungunya
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Zika Virus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Mosquito Borne Disease Market, By Treatment Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Medication
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Vaccination
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Vector Control Methods
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bin)
• Immunotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Supportive Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Mosquito Borne Disease Market, By End User, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Government Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• NGOs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Mosquito Borne Disease Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi S.A.
• Pfizer Inc.
• Merck & Co., Inc.
• Novartis AG
• Johnson & Johnson
• Eisai Co., Ltd
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Valeant Pharmaceuticals International, Inc.
• Mitsubishi Tanabe Pharma Corporation
• Abbott
• Hoffmann-La Roche Ltd
• Sun Pharmaceutical Industries Ltd
• Lupin Pharmaceuticals, Inc.
• BioCryst Pharmaceuticals, Inc.
• Mallinckrodt Pharmaceuticals
• Serum Institute of India Pvt. Ltd.
• CSL Limited
• Teva Pharmaceutical Industries Ltd
• Analyst Views

10. Section

• Research Methodology
• About us